A Mobile App to Enhance Behavioral Activation Treatment for Substance Use Disorder: App Design, Use, and Integration Into Treatment in the Context of a Randomized Controlled Trial.
A Mobile App to Enhance Behavioral Activation Treatment for Substance Use Disorder: App Design, Use, and Integration Into Treatment in the Context of a Randomized Controlled Trial.
复制标题
DOI：
10.2196/25749
复制
发表时间：
2021-11-03
影响因子：
2.2
通讯作者：
Daughters SB
中科院分区：
文献类型：
--
作者：
Paquette CE;Rubalcava DT;Chen Y;Anand D;Daughters SB
通常在低资源物质使用障碍（SUD）治疗环境中使用的基于组的格式导致很少的个人关注，以帮助加强和指导技能的使用，这可能导致治疗后结果不佳。智能手机应用程序提供了一种方便、用户友好且具有成本效益的工具，可以扩展有效SUD治疗的范围。开发了一款智能手机应用程序，并将其整合到SUD的基于小组的简短行为激活（BA）治疗中，以增加临床医生管理会话之外的治疗技能参与。本研究旨在描述应用程序的功能及其使用和整合到治疗中，报告参与者自我报告的应用程序的可行性和可接受性，并讨论挑战，并为未来智能手机应用程序整合到SUD的行为治疗中提供建议。共有56名从强化门诊SUD治疗中招募的个体接受了智能手机增强的BA治疗，即物质使用的生命增强治疗。在治疗后以及1个月和3个月随访时评估了自我报告的每周应用程序使用情况和不使用原因。此外，双尾t检验和卡方检验比较了每个应用程序组件的自我报告使用情况和一段时间内的整体应用程序使用情况。参与者的反馈表明，将智能手机应用程序整合到物质使用的生命增强治疗中是可行的，并且被广泛接受，参与者发现该应用程序对于计划会话之外的基于价值的活动很有用。自我报告的应用程序参与度在随访期间下降：72%（39/54）的参与者报告在治疗后使用应用程序，在1个月随访时下降至69%（37/54），在3个月随访时下降至37%（20/54）。参与者报告说，忘记使用该应用程序是不使用的主要原因。这项研究为智能手机增强BA治疗的可行性和可接受性提供了支持，为未来测试技术整合到SUD治疗中的研究提供了希望。设计决策可能有助于简化智能手机与治疗的整合，例如，允许参与者在自己的手机上下载治疗应用程序或使用低成本的研究智能手机（或提供两种选择）。可以通过内置提醒、提醒和应用内消息来提高应用的长期参与度。ClinicalTrials.gov NCT02707887; https://clinicaltrials.gov/ct2/show/study/NCT02707887
Group-based formats typically used in low-resource substance use disorder (SUD) treatment settings result in little individual attention to help reinforce and guide skill use, which may contribute to poor posttreatment outcomes. Smartphone apps offer a convenient, user-friendly, and cost-effective tool that can extend the reach of effective SUD treatments. A smartphone app was developed and integrated into a group-based, brief behavioral activation (BA) treatment for SUD to increase engagement in treatment skills outside clinician-administered sessions. This study aims to describe the features of the app and its use and integration into treatment, report the participants’ self-reported feasibility and acceptability of the app, and discuss challenges and provide recommendations for future smartphone app integration into behavioral treatments for SUD. A total of 56 individuals recruited from intensive outpatient SUD treatment received a smartphone-enhanced BA treatment, the Life Enhancement Treatment for Substance Use. Self-reported weekly app use and reasons for nonuse were assessed at posttreatment and at 1- and 3-month follow-ups. In addition, 2-tailed t tests and chi-square tests compared the self-reported use of each app component and overall app use over time. Participant feedback suggested that the integration of the smartphone app into the Life Enhancement Treatment for Substance Use was feasible and well accepted, and participants found the app useful for planning value-based activities outside of sessions. Self-reported app engagement decreased over the follow-up period: 72% (39/54) of participants reported using the app at posttreatment, decreasing to 69% (37/54) at the 1-month follow-up and 37% (20/54) at the 3-month follow-up. Participants reported forgetting to use the app as a primary reason for nonuse. This study provides support for the feasibility and acceptability of smartphone-enhanced BA treatment, offering promise for future research testing the integration of technology into SUD treatment. Design decisions may help streamline smartphone integration into treatment, for example, allowing participants to download the treatment app on their own phones or use a low-cost study smartphone (or offering both options). Long-term app engagement may be increased via built-in reminders, alerts, and in-app messages. ClinicalTrials.gov NCT02707887; https://clinicaltrials.gov/ct2/show/study/NCT02707887
登录
查看更多内容
影响因子：
25.8
作者：
Gustafson, David H.;McTavish, Fiona M.;Chih, Ming-Yuan;Atwood, Amy K.;Johnson, Roberta A.;Boyle, Michael G.;Levy, Michael S.;Driscoll, Hilary;Chisholm, StevenM.;Dillenburg, Lisa;Isham, Andrew;Shah, Dhavan
通讯作者：
Shah, Dhavan
DOI：
10.1111/add.14049
发表时间：
2018-03
期刊：
Addiction (Abingdon, England)
影响因子：
--
作者：
Daughters SB;Magidson JF;Anand D;Seitz-Brown CJ;Chen Y;Baker S
通讯作者：
Baker S
影响因子：
5.3
作者：
Sheehan, DV;Lecrubier, Y;Dunbar, GC
通讯作者：
Dunbar, GC
影响因子：
5
作者：
Hernandez-Reyes, Alberto;Camara-Martos, Fernando;Moreno Rojas, Rafael
通讯作者：
Moreno Rojas, Rafael
影响因子：
120.7
作者：
McLellan, AT;Lewis, DC;Kleber, HD
通讯作者：
Kleber, HD